Find in Library

This paper performed a retrospective analysis of 19 patients diagnosed with pathologically-verified WHO Ⅱ-Ⅲ grade glioma with T2/FLAIR mismatch sign. We extracted the overall characteristics of the tumor area and the image parameters of the mismatch regions from the patients' imaging data for quantitative analysis. Afterward, we investigated how T2/FLAIR mismatch sign affected the diagnostic efficacy for isocitrate dehydrogenase (IDH)-mutant and 1p/19q non-codeleted (IDHMUT/1p/19q+) lower-grade gliomas (LGG). This study showed that the overall and partial T2/FLAIR mismatch sign can be used as an imaging marker to predict IDHMUT/1p/19q+ LGG. The overall imaging characteristics of the tumor area combined with the quantitative parameters of the mismatch regions can improve the diagnostic efficacy for IDHMUT/1p/19q+ LGG.